Welichem Biotech Inc.
Records under this name other than the patents Welichem Biotech Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.
Showing 1 to 10 of 10 · Back to Welichem Biotech Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,487,009 | Novel 1,2-Diphenylethene Derivatives for Treatment of Immune Diseases Formerly held Term ended Term ended Apr 4, 2023 · Medium confidence | Term ended | Term ended Apr 4, 2023 | Medium confidence |
| US 7,321,050 | Anti-Inflammatory and Psoriasis Treatment and Protein Kinase Inhibition by Hydroxy Stilbenes and Novel Stilbene Derivatives and Analogues Formerly held Term ended Term ended Dec 25, 2022 · Medium confidence | Term ended | Term ended Dec 25, 2022 | Medium confidence |
| US 7,868,047 | Anti-Inflammatory and Psoriasis Treatment and Protein Kinase Inhibition by Hydroxy Stilbenes and Novel Stilbene Derivatives and Analogues Formerly held Term ended Term ended Dec 6, 2020 · Medium confidence | Term ended | Term ended Dec 6, 2020 | Medium confidence |
| US 8,071,637 | Dithiolopyrrolones compounds and their therapeutic applications Lapsed on the fee record Ended Dec 6, 2019 · USPTO record | Lapsed on the fee record | Ended Dec 6, 2019 | USPTO record |
| US 9,051,330 | Dithiolopyrrolones with therapeutic activity Lapsed on the fee record Ended Jun 9, 2019 · USPTO record | Lapsed on the fee record | Ended Jun 9, 2019 | USPTO record |
| US 6,583,171 | Antineoplastic agents Term ended Term ended Apr 4, 2016 · USPTO record | Term ended | Term ended Apr 4, 2016 | USPTO record |
| US 6,316,476 | Heterocyclic compounds with antibacterial and antimycotic properties Lapsed on the fee record Ended Nov 13, 2013 · USPTO record | Lapsed on the fee record | Ended Nov 13, 2013 | USPTO record |
| US 6,020,360 | Anticancer property of dithiolopyrrolones Lapsed on the fee record Ended Feb 1, 2012 · USPTO record | Lapsed on the fee record | Ended Feb 1, 2012 | USPTO record |
| US 5,569,668 | Indole derivatives with antibacterial and antimycotic properties Term ended Term ended no later than Oct 29, 2016 · Low confidence | Term ended | Term ended no later than Oct 29, 2016 | Low confidence |
| US 5,827,872 | Xenomins novel heterocyclic compounds with antimicrobial and antneoplastic properties Term ended Term ended no later than Oct 27, 2018 · Low confidence | Term ended | Term ended no later than Oct 27, 2018 | Low confidence |